| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |